Table 1 Summary of patients’ characteristics by gender
Patients' characteristics and test parameters | Males n = 213 | Females n = 80 | Total n = 293 |
|---|---|---|---|
Age group | |||
Mean ± SD | 42.30 ± 14.1 | 39.96 ± 13.01 | 41.66 ± 13.84 |
Median (min–max) | 42.0 (16–78) | 39.0 (16–73) | 41.0 (16–78) |
Less than 20 (%) | 8 (2.7) | 4 (1.4) | 12 (4.1) |
21–30 (%) | 47 (16.0) | 17 (5.8) | 64 (21.8) |
31–40 (%) | 45 (15.4) | 24 (8.2) | 69 (23.5) |
41–50 (%) | 58 (19.8) | 21 (7.2) | 79 (27.0) |
50 and above (%) | 55 (18.8) | 14 (4.8) | 69 (23.5) |
ALT (U/L) | |||
Mean ± SD | 31.5.50 ± 21.20 | 31.94 ± 22.87 | 31.625 ± 21.63 |
Median (min–max) | 27.0 (5.0–238.3) | 25.25 (10.5–150.6) | 26.0 (5.0–238.0) |
Normal | 181 (61.8) | 68 (23.2) | 249 (85.0) |
Elevated | 32 (10.9) | 12 (4.1) | 44 (15.0) |
AST (U/L) | |||
Mean ± SD | 31.1 ± 36.4 | 32.7 ± 31.9 | 31.5 ± 35.2 |
Median (min–max) | 25.2 (8.7–522) | 26.0 (6.1–201) | 25.4 (6.1–522) |
Normal | 187 (63.8) | 71 (24.2) | 258 (88.1) |
Elevated | 26 (8.9) | 9 (3.1) | 35 (11.9) |
HBV Viral load (Log IU) | |||
Mean ± SD | 3.48 ± 1.08 | 3.45 ± 1.42 | 3.74 ± 1.17 |
Median (min–max) | 3.49 (1.30–6.68) | 3.28 (1.30–7.95) | 3.47 (1.30–7.95) |
< 2000 IU/ml | 162 (55.3) | 64 (80.0) | 226 (77.1) |
2001–20,000 IU/ml | 33 (11.3) | 7 (2.4) | 40 (13.7) |
20,000–200,000 IU/ml | 11 (3.8) | 7 (2.4) | 18 (6.1) |
> 200,001 IU/ml | 7 (2.4) | 2 (0.7) | 9 (3.1) |
Diagnostic criteria for CHB patients according to AASLD | |||
Immune-Tolerant | 2 (0.7) | 1 (0.3) | 3 (1.0) |
Immune-Active CHB | 43 (14.7) | 15 (5.1) | 58 (19.8) |
Inactive CHB | 168 (57.3) | 64 (21.8) | 232 (79.2) |